Toll Free Number Toll Free: 1800 103 1369 Email Us Email Us: customercare@canmoney.in
Market

DIVI'S LABORATORIES LTD.

  • NSE CodeDIVISLABEQ
  • BSE Code532488
  • ISININE361B01024
  • IndustryPharmaceuticals


Company Information

Management

Mr. M Satish Choudhury

Co. Secretary & Compl. Officer

Mr. Venkatesa Perumallu Pasumarthy

Chief Financial Officer

Incorporation Year

12/10/1990

Registered Address

Registered Office : Divi Towers, 1-72/23(P)/DIVIS/303, , Cyber Hills, Gachibowli,
Hyderabad, Telangana - 500032
Tel: 040-66966300
Fax: 040-66966460

Registrar Office

KFIN Technologies Pvt. Ltd.
Selenium Tower B, Plot No. 31-32,Gachibowli, Financial District, Nanakramguda,Serilingampally Man
Hyderabad,500032,Telangana
Tel: 040-67161500
Fax: 23420814

Email

mail@divislabs.com

Website

http://www.divislabs.com

Listing

BSE, MCXSX, NSE, NSE

Corporate News

Divi's Laboratories - Board Meeting Intimation for Co...

22-Oct-2026|4:57PM

Divis Laboratories Ltdhas informed BSE that the meeting of the Board of Dir

Divi's Laboratories has submitted to BSE the Sharehol...

06-Oct-2026|3:30PM

As of September 2026, 51.87% is owned by Indian Promoters and 48.12% by Pub

Divi's Laboratories - Certificate under SEBI (Deposit...

06-Oct-2026|12:27PM

Divi's Laboratories Limited has informed the Exchange about Certificate und

Divi's Laboratories - Compliances-Certificate under R...

06-Oct-2026|12:22PM

Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the q

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug106.26301.29
Aarti Drug435.203,972.07
Aarti Pharma872.707,913.63
Abbott India25,635.0054,472.59
Accent Micro639.001,532.90

MF Holding

Scheme NameValue
(₹ Cr)
Holding (%)
SBI Large Cap..1888.063.61
HDFC Flexi Ca..1759.681.62
SBI Aggressiv..1579.561.83
SBI Focused F..1207.902.41
Axis ELSS Tax..830.242.74

Board Meetings

DatePurpose
07/11/2026Quarterly Results
01/08/2026Quarterly Results
23/05/2026Audited Results & D..
11/02/2026Quarterly Results
07/11/2025Quarterly Results